ArticleJCI insight2017
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.
Fumi Sato-Kaneko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
174 papers cite itlatest 60 shown
this paperpooled ittrialcites it